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Background. We sought to evaluate the diagnostic accuracy of 64-slice multi-detector row
computed tomography (MDCT) compared with invasive coronary angiography for in-stent
restenosis (ISR) detection.
Methods. MEDLINE, Cochrane library, and BioMed Central database searches were
performed until April 2009 for original articles. Inclusion criteria were (1) 64-MDCT was used
as a diagnostic test for ISR, with >50% diameter stenosis selected as the cut-off criterion for
significant ISR, using invasive coronary angiography and quantitative coronary angiography as
the standard of reference; (2) absolute numbers of true positive, false positive, true negative,
and false negative results could be derived. Standard meta-analytic methods were applied.
Results. Nine studies with a total of 598 patients with 978 stents included were considered
eligible. On average, 9% of stents were unassessable (range 0-42%). Accuracy tests with 95%
confidence intervals (CIs) comparing 64-MDCT vs invasive coronary angiography showed that
pooled sensitivity, specificity, positive and negative likelihood ratio (random effect model)
values were: 86% (95% CI 80-91%), 93% (95% CI 91-95%), 12.32 (95% CI 7.26-20.92), 0.18
(95% CI 0.12-0.28) for binary ISR detection. The symmetric area under the curve value was
0.94, indicating good agreement between 64-MDCT and invasive coronary angiography.
Conclusions. 64-MDCT has a good diagnostic accuracy for ISR detection with a particu-
larly high negative predictive value. However, still a relatively large proportion of stents
remains uninterpretable. Accordingly, only in selected patients, 64-MDCT may serve as a
potential alternative noninvasive method to rule out ISR. (J Nucl Cardiol 2010;17:470–8.)
Key Words: Meta-analysis Æ in-stent restenosis Æ computed tomography coronary
angiography
INTRODUCTION
Coronary stent implantation is increasingly per-
formed in the treatment of significant coronary artery
disease and has significantly reduced the occurrence of
restenosis as compared with balloon angioplasty.1,2
Moreover, with the recent introduction of drug-eluting-
stents (DES), the occurrence of in-stent restenosis (ISR)
has further decreased.3,4 Nonetheless, even after DES
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implantation, excessive neo-intimal hyperplasia result-
ing in partial or complete ISR may still occur.
Accordingly, in patients presenting with recurrent chest
pain following DES implantation, invasive coronary
angiography remains frequently indicated to evaluate
the presence of ISR. However, considering the fact that
a substantial number of these invasive coronary angio-
grams are not followed by intervention, the need for a
noninvasive alternative approach for ISR detection is
evident. To this end, stress tests may be used to assess
patients with suspicion of ISR. However, the diagnostic
accuracy of stress tests for ISR detection is moderate,5
and direct stent visualization would be preferred. With
previous 4- and 16-slice multi-detector row computed
tomography (MDCT) systems, MDCT was of limited
value in the assessment and follow-up of patients with
coronary stents, due to the frequent occurrence of
motion and blooming artefacts.6,7 With the introduction
of 64-slice systems, some of these limitations have been
partially overcome due to increased temporal resolution
(due to increased gantry rotation speed), increased spa-
tial resolution and enhanced craniocaudal coverage.
Although initial data obtained with 64-MDCT appear
promising, more robust data are needed to confirm that
this technique may become a potential alternative to
invasive coronary angiography for ISR detection in daily
clinical practice. The most important features of a
clinical test are few false negative and false positive
results (affecting sensitivity and specificity, respec-
tively). Additionally, when restenosis rate is low, as it is
currently the case for simple lesions treated with DES, a
high negative predictive value (NPV) allows exclude
ISR in the majority of patients. Subsequently, only in a
limited number of patients, invasive coronary angiog-
raphy would be required to confirm and potentially treat
ISR.
In order to determine the current diagnostic accu-
racy of 64-MDCT, we performed a meta-analysis of all
available studies comparing 64-MDCT with invasive
coronary angiography for the diagnosis of ISR.
METHODS
Search Strategy
Database searches for English articles published until
April 2009 were performed in MEDLINE, Cochrane library,
and BioMed Central databases. We combined the medical
subject headings for computed tomography, multi-detector
computed tomography, and coronary angiography, with the
exploded terms stent and restenosis and scanned references in
retrieved articles and reviews. The retrieved studies were
carefully examined to exclude potential duplicates or over-
lapping data. Meeting abstracts were excluded, as they could
not provide adequately detailed data and their results might not
be final. Only papers evaluating the presence of ISR by both
invasive coronary angiography and 64-MDCT in the same
subjects were included.
Study Eligibility
We included a study if: (1) 64-MDCT was used as a
diagnostic test for ISR, with [50% diameter stenosis selected
as the cut-off criterion for significant restenosis, using invasive
coronary angiography and quantitative coronary angiography
as the standard of reference; (2) absolute numbers of true
positive (TP), false positive (FP), true negative (TN), and false
negative (FN) results were provided or could be derived.
Studies were excluded if they were performed: (1) only in
patients after coronary artery bypass graft surgery; (2) in a
subset of patients with prior heart transplantation.
Data Extraction
The following information was extracted from each study:
first author, year of publication, and journal; study population
characteristics, including sample size (number of subjects
evaluated with both tests, number of patients excluded);
number of stents evaluated (and excluded from the analysis);
gender; mean age (and standard deviation); mean heart rate
(and standard deviation); relative timing of the two imaging
procedures and whether or not evaluation of one test was blind
to the result of the other; technical characteristics of the
MDCT, including type and manufacturer of MDCT equipment
used, and rate of beta-blocker usage. Two investigators per-
formed data extraction independently. Discrepancies were
solved by a third investigator and global consensus. The study
quality conformed to the QUADAS guidelines.8
Statistical Analysis
The main analyses were performed using the traditional
meta-analytic methods for combining data for diagnostic
accuracy tests.9,10 The analyses that were performed to com-
pare accuracy of 64-MDCT vs invasive coronary angiography
as reference incorporated all accuracy tests separately: sensi-
tivity, specificity, likelihood ratios, diagnostic odds ratio, and
finally summarizing data in receiver operating characteristic
curves (sROC). Accordingly, the absolute numbers of TP, FP,
TN, and FN findings were analyzed to provide sensitivity and
specificity. Positive and negative likelihood ratios (LR? and
LR-) were calculated as LR? = sensitivity/(1 - specificity)
and LR- = (1 - sensitivity)/specificity, respectively. The
LR? is a measure of how much the odds of the disease
increase when a test is positive, while the LR- is a measure of
how much the odds of the disease decrease when a test is
negative. Thus, the combined likelihood ratios provides
the diagnostic odds ratio (=[sensitivity/(1 - specificity)]/
[(1 - specificity/sensitivity] = (true positive 9 true negative)/
(false positive 9 false negative)). The result is a ratio of the
odds of a positive test result among diseased to the odds of a
positive test result among nondiseased.9,10 Diagnostic odds
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ratio converts each pair of sensitivity and specificity into a
single global accuracy measure.
Sensitivity and specificity were pooled as weighted means
in which the weight of each study is its sample size. Likelihood
ratios and diagnostic odds ratios were pooled by the DerSi-
monian and Laird method (random-effects model).11 The
accuracy tests were repeated with inclusion of unassessable
stents. The summary ROC analysis, that represents a more
general method for the meta-analysis of diagnostic studies than
those described above, was computed using the Moses-Shap-
iro-Littenberg method.12
Source of heterogeneity were explored performing a
meta-regression using the Moses-Shapiro-Littenberg method
with covariates12: average age of patients, percentage of male,
percentage of not evaluable stents, sample size.
Meta-analysis software package Meta-disc version 1.4
(Unit of clinical biostatics, the Ramo y Cajal Hospital, Madrid,
Spain) was used for analyses. Moreover, prevalence of ISR,
positive, and negative predictive values were calculated as
well.
Finally, to check how robust our findings were to model
specification we also performed a sensitivity analysis. Rather
than using a single accuracy endpoint per study we used a
multivariate meta-analysis model. We used the hierarchical
summary ROC model which in our setting represents a dif-
ferent parametrization of the bivariate random-effects meta-
analysis model.13 Additional analysis was conducted using
STATA/SE 10.1 (Stata Statistical Software: Release 10.
College Station, TX: StataCorp LP).
RESULTS
Search Results
The search resulted in detection of 211 hits. After
the exclusion of nonrelevant articles by title and
abstract, 37 articles were retrieved for full text evalua-
tion, and of these 10 studies fulfilled all inclusion
criteria. One study was excluded because it was per-
formed using a dual-source 64-slice MDCT system.14
From the study by Rist et al15 the data on proximal,
distal, and in-stent restenosis were combined to a single
result. Despite using a 40-MDCT system, the study by
Gaspar et al16 was included as the spatial resolution was
similar to 64-MDCT. Finally, for this reason, the study
by Van Mieghem et al,17 which used both 16- and
64-slice scanners, was also included in the analysis.
Accordingly, nine eligible studies15-23 were included in
the meta-analysis (Table 1).
Characteristics of the Included Studies
The mean patient age was 61 years with a range of
58-68 years. Males constituted 81% (range 63-92%),
and 17% (range 12-27%) had diabetes mellitus. The
mean heart rate during data acquisition (reported in six T
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studies) was 62 beats per min with a range of 54-72
beats per min. In five studies patients received additional
beta-blockers to reduce heart rate before the examina-
tion (Table 1).
Stent Assessability
The analysis included 598 patients with a total of
978 stents. The percent of DES evaluated was 56% (data
available in six studies). Overall the percent of unas-
sessable stents was 9% (range 0-42%), although in three
studies all stented segments were evaluated17,19,22
(Table 1).
Results of the Accuracy Analyses
After the exclusion of unassessable stents, accuracy
tests with 95% confidence intervals (CIs) comparing
64-MDCT vs invasive coronary angiography for binary
ISR detection showed that pooled sensitivity, specificity,
positive likelihood ratio, negative likelihood ratio, and a
diagnostic odds ratio (random effect model) values were
86% (95% CI 80-91%) (Figure 1A), 93% (95% CI
91-95%) (Figure 1B), 12.32 (95% CI 7.26-20.92)
(Figure 2A), 0.18 (95% CI 0.12-0.28) (Figure 2B), and
88.9 (95% CI 34.6-228.6), respectively. The area under
the sROC curve was 0.94 for per-stent analysis, indi-
cating a high degree of agreement between 64-MDCT
and invasive coronary angiography for ISR detection
(Figure 3). Visual inspection of Figures 1 and 2 identi-
fied the presence of heterogeneity between studies.
However, heterogeneity was found statistically signifi-
cant for specificity (v2 = 25.81, df = 8, P = .0011),
and positive likelihood ratio (v2 = 24.91, df = 8, P =
.002). The calculated positive and negative predictive
values were 70.4% and 97.2%, respectively. When
including unassessable stents, accuracy tests showed that
value of the pooled sensitivity did not change (86%,
95% CI 80-91%), whereas the pooled specificity only
slightly decreased (91%, 95% CI 87-92%).
Figure 1. (A) Plot and table of in-stent restenosis detection sensitivity of 64-MDCT vs invasive
coronary angiography; (B) plot and table of ISR detection specificity of 64-slice multi-detector
computed tomography vs invasive coronary angiography.
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Heterogeneity Analyses
The meta-regression analysis to explore the reasons
of heterogeneity, including all important covariates,
which we presumed to be the most likely source of
heterogeneity, did not show any significant effect.
Quality assessment for all included studies is shown in
Table 2.
Additional Analyses
Results from the bivariate meta-analysis model
show negligible differences. Sensitivity, specificity,
positive and negative likelihood ratios, and diagnostic
odds ratio pooled estimates were 88 (95% CI 80-93%),
94% (95% CI 90-96%), 13.8 (95% CI 8.2-23.2), 0.13
(95% C 0.1-0.2), and 107.20 (95% CI 42.9-267.9),
respectively.
DISCUSSION
In this meta-analysis, we focused on the diagnostic
performance of the 64-MDCT generation of MDCT as a
potential alternative, noninvasive method for ISR
detection. We observed an average weighted sensitivity
of 86% and specificity of 93% for 64-MDCT in the
detection of ISR as compared to invasive coronary
angiography. These observations are not substantially
different from the meta-analysis by Hamon et al, who
included both 16- and 64-MDCT systems.24 While in
fact the majority of data were derived from the older
16-MDCT systems, only slightly lower average weigh-
ted sensitivity (84%) and specificity (91%) were
reported. However, one should realize that both in the
meta-analysis of Hamon et al24 as well as the current
one, these values were obtained after exclusion of un-
interpretable stents. Possibly, the main advantage of
improved temporal and spatial resolution may lie in
improved rates of interpretable stents. Indeed, with
previous generations of MDCT scanners, diagnosis of
ISR was particularly limited by the high percentages of
stents with insufficient image quality for evaluation.
Based on in vitro studies as well as initial clinical
investigations, improvement in the rate of interpretable
stents has been anticipated with the introduction of 64-
MDCT with higher spatial and temporal resolution.15,25
Figure 2. (A) Plot and table of in-stent restenosis detection negative likelihood ratio of 64-MDCT
vs invasive coronary angiography; (B) plot and table of in-stent restenosis detection positive
likelihood ratio of 64-slice multi-detector computed tomography vs invasive coronary angiography.
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However, thus far no robust data were available to sup-
port this expectation. Previous meta-analyses addressing
the value of MDCT in the detection of ISR still reported
high rates of uninterpretable stents of approximately
13%.24,26 Importantly, these meta-analyses, as described
above, included both 16- and 64-MDCT with the
majority of data derived from the older 16-MDCT sys-
tems. In contrast, the current analysis was restricted to
64-MDCT and showed a relatively slight reduction in the
rate of nonassessable stents (9%) as compared to these
previous meta-analyses (absolute reduction of 4.4%;
relative reduction of 30%). Accordingly, the current
analysis supports that the use of 64-MDCT may indeed
result in improved stent assessability.
However, despite this improvement as compared to
previous investigations, the rate of uninterpretable stents
was still not negligible. Moreover, the majority of
included studies used strict inclusion criteria with
exclusion of patients with smaller stents, contraindica-
tion to administration of beta-blocking medication,
elevated heart rate and obesity. In previous studies, these
factors have been shown to negatively influence stent
evaluation with MDCT.7,27,28 Indeed, as can be derived
from Table 1, also in the currently included studies,
rates of uninterpretable stents tended to be higher in the
presence of a higher mean heart rate, no additional
administration of beta-blocking medication or a rela-
tively higher proportion of stents with a diameter
\3.0 mm. Of note, the results of the present meta-
analyses showed significant heterogeneity between the
included studies. Thus, our results should be interpreted
cautiously, although the use of the random-effects model
and the bivariate random-effects meta-analysis model
should at least partly correct for this issue. Exploring
sources of heterogeneity by meta-regression analyses
showed that age, percentage of male, percentage of
nonevaluable stents and sample size had no significant
influence. Possible sources of heterogeneity were a
significant difference in the numbers of assessed stents
between studies and the use of kernel convolution filters,
which might have influenced the absolute numbers of
true and false ISR reported in each study. These varia-
tions in-stent analysis may be attributed to the level of
experience with 64-MDCT in different study centers.
Improvement of technical quality and clinical experi-
ence might minimize this difference.
Figure 3. Receiver operator characteristic (ROC) curve analysis on a per stented segment basis
(nine studies) comparing 64-MDCT vs invasive coronary angiography. The diagnostic accuracy is
shown by plotting 1-specificity against sensitivity, area under curve (AUC), and Q* statistic with
their standard errors (SE). The upper and lower lines indicate 95% CIs. SROC Summary receiver
operating characteristics.
Journal of Nuclear Cardiology Carrabba et al 475
Volume 17, Number 3;470–8 64-Slice computed tomography coronary angiography for detection of ISR
T
a
b
le
2
.
Q
u
a
li
ty
a
ss
e
ss
m
e
n
t
(Q
U
A
D
A
S
)
S
tu
d
y
It
e
m
1
It
e
m
2
It
e
m
3
It
e
m
4
It
e
m
5
It
e
m
6
It
e
m
7
It
e
m
8
It
e
m
9
It
e
m
1
0
It
e
m
1
1
It
e
m
1
2
It
e
m
1
3
It
e
m
1
4
G
a
sp
a
r
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
V
a
n
M
ie
g
h
e
m
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
R
ix
e
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
R
is
t
Y
e
s
Y
e
s
Y
e
s
N
o
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
E
h
a
ra
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
O
n
c
e
l
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
C
a
d
e
m
a
rt
ir
i
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
C
a
rr
a
b
b
a
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
M
a
n
g
h
a
t
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
A
ll
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
Y
e
s
It
e
m
1
:
w
a
s
th
e
sp
e
c
tr
u
m
o
f
p
a
ti
e
n
ts
re
p
re
se
n
ta
ti
v
e
o
f
th
e
p
a
ti
e
n
ts
w
h
o
w
il
l
re
c
e
iv
e
th
e
te
st
in
p
ra
c
ti
c
e
?
It
e
m
2
:
w
e
re
se
le
c
ti
o
n
c
ri
te
ri
a
c
le
a
rl
y
d
e
sc
ri
b
e
d
?
It
e
m
3
:
is
th
e
re
fe
re
n
c
e
st
a
n
d
a
rd
li
k
e
ly
to
c
o
rr
e
c
tl
y
c
la
ss
if
y
th
e
ta
rg
e
t
c
o
n
d
it
io
n
?
It
e
m
4
:i
s
th
e
ti
m
e
p
e
ri
o
d
b
e
tw
e
e
n
re
fe
re
n
c
e
a
n
d
st
a
n
d
a
rd
a
n
d
in
d
e
x
te
st
sh
o
rt
e
n
o
u
g
h
to
b
e
re
a
so
n
a
b
ly
su
re
th
a
t
th
e
ta
rg
e
t
c
o
n
d
it
io
n
d
id
n
o
t
c
h
a
n
g
e
b
e
tw
e
e
n
th
e
tw
o
te
st
s?
It
e
m
5
:
d
id
th
e
w
h
o
le
sa
m
p
le
o
r
a
ra
n
d
o
m
se
le
c
ti
o
n
o
f
th
e
sa
m
p
le
,
re
c
e
iv
e
v
e
ri
fi
c
a
ti
o
n
u
si
n
g
a
re
fe
re
n
c
e
st
a
n
d
a
rd
o
f
d
ia
g
n
o
si
s?
It
e
m
6
:
d
id
th
e
p
a
ti
e
n
ts
re
c
e
iv
e
th
e
sa
m
e
re
fe
re
n
c
e
st
a
n
d
a
rd
re
g
a
rd
le
ss
o
f
th
e
in
d
e
x
te
st
re
su
lt
s?
It
e
m
7
:
w
a
s
th
e
re
fe
re
n
c
e
st
a
n
d
a
rd
in
d
e
p
e
n
d
e
n
t
o
f
th
e
in
d
e
x
te
st
(i
.e
.,
th
e
in
d
e
x
te
st
d
id
n
o
t
fo
rm
p
a
rt
o
f
th
e
re
fe
re
n
c
e
st
a
n
d
a
rd
)?
It
e
m
8
:
w
a
s
th
e
e
x
e
c
u
ti
o
n
o
f
th
e
in
d
e
x
te
st
d
e
sc
ri
b
e
d
in
th
e
su
ffi
c
ie
n
t
d
e
ta
il
to
p
e
rm
it
re
p
li
c
a
ti
o
n
o
f
th
e
te
st
?
It
e
m
9
:
w
a
s
th
e
e
x
e
c
u
ti
o
n
o
f
th
e
re
fe
re
n
c
e
st
a
n
d
a
rd
d
e
sc
ri
b
e
d
in
th
e
su
ffi
c
ie
n
t
d
e
ta
il
to
p
e
rm
it
it
s
re
p
li
c
a
ti
o
n
?
It
e
m
1
0
:
w
e
re
th
e
in
d
e
x
te
st
re
su
lt
s
in
te
rp
re
te
d
w
it
h
o
u
t
k
n
o
w
le
d
g
e
o
f
th
e
re
su
lt
s
o
f
th
e
re
fe
re
n
c
e
st
a
n
d
a
rd
?
It
e
m
1
1
:
w
e
re
th
e
re
fe
re
n
c
e
st
a
n
d
a
rd
re
su
lt
s
in
te
rp
re
te
d
w
it
h
o
u
t
k
n
o
w
le
d
g
e
o
f
th
e
re
su
lt
s
o
f
th
e
in
d
e
x
te
st
?
It
e
m
1
2
:
w
e
re
th
e
sa
m
e
c
li
n
ic
a
l
d
a
ta
a
v
a
ila
b
le
w
h
e
n
te
st
re
su
lt
s
w
e
re
in
te
rp
re
te
d
a
s
w
o
u
ld
b
e
a
v
a
ila
b
le
w
h
e
n
th
e
te
st
is
u
se
d
in
p
ra
c
ti
c
e
?
It
e
m
1
3
:
w
e
re
u
n
in
te
rp
re
ta
b
le
/i
n
te
rm
e
d
ia
te
te
st
re
su
lt
s
re
p
o
rt
e
d
?
It
e
m
1
4
:
w
e
re
w
it
h
d
ra
w
a
ls
fr
o
m
th
e
st
u
d
y
e
x
p
la
in
e
d
?
476 Carrabba et al Journal of Nuclear Cardiology
64-Slice computed tomography coronary angiography for detection of ISR May/June 2010
Clinical Implications
The current meta-analysis confirms that in selected
patients, 64-MDCT can reliably rule out ISR. The high
NPV of 97.2% indicates that if stent patency is demon-
strated on 64-MDCT, further evaluation by means of
invasive coronary angiography can be avoided. Accord-
ingly, the technique may be a particularly suitable
alternative for patients without a high clinical suspicion
of ISR and with expected low rate of ISR, but in whom
further clinical evaluation is still preferred. However,
patients with a high likelihood of ISR, including patients
with typical chest pain and/or an unambiguously abnor-
mal stress test, are unlikely to benefit from initial
noninvasive evaluation with MDCT. In this patient
population, MDCT is limited by its low positive predic-
tive value, inability to determine the hemodynamical
relevance of detected lesions and the fact that no imme-
diate intervention can be performed. Accordingly, use of
MDCT may only result in unnecessary radiation expo-
sure, although recent developments in technology and
software currently allow coronary CT angiography with
estimated doses\5 mSv.29,30 In addition, MDCT imag-
ing remains unsuitable for patients with characteristics
unfavorable for stent imaging, such as small stents or
elevated heart rate. Indeed, it remains important to realize
that even with 64-MDCT only in selected patients, the
high diagnostic accuracy and relatively low rates of
uninterpretable stents are maintained. Routine use of
64-MDCT to rule out ISR in the general population
therefore, cannot be recommended. Potentially, improved
rates of stent interpretation may be achieved in the near
future with the use of dual-source systems with higher
temporal resolution,14 high-definition or flat panel
detector scanners with improved spatial resolution31,32 or
even 320-row systems that allow cardiac imaging in a
single volume.33
CONCLUSIONS
The results of the current meta-analysis demonstrate
that 64-MDCT has a good diagnostic accuracy for ISR
detection with a particularly high NPV. However, still a
relatively large proportion of stents, although improved
as compared to previous reports, remains uninterpret-
able. Accordingly, only in selected patients, 64-MDCT
may serve as a potential alternative noninvasive method
to rule out ISR.
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